OTL-38

OTL-38 Uses, Dosage, Side Effects, Food Interaction and all others data.

OTL-38 is under investigation in clinical trial NCT02769533 (A Phase 1, Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection (OTL38) for Intra-operative Imaging of Folate Receptor-alpha Positive Pituitary Adenoma).

Trade Name OTL-38
Generic OTL-38
Type
Formula C61H67N9O17S4
Weight Average: 1326.49
Monoisotopic: 1325.353776429
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
OTL-38
OTL-38

Innovators Monograph

You find simplified version here OTL-38

*** Taking medicines without doctor's advice can cause long-term problems.
Share